AMATO, Rosario
 Distribuzione geografica
Continente #
NA - Nord America 690
EU - Europa 318
AS - Asia 160
Continente sconosciuto - Info sul continente non disponibili 6
SA - Sud America 3
OC - Oceania 1
Totale 1.178
Nazione #
US - Stati Uniti d'America 672
IT - Italia 215
SG - Singapore 82
CN - Cina 67
SE - Svezia 39
GB - Regno Unito 31
CA - Canada 18
DE - Germania 13
IN - India 6
EU - Europa 5
FI - Finlandia 5
NL - Olanda 5
CL - Cile 2
CZ - Repubblica Ceca 2
ES - Italia 2
JP - Giappone 2
LT - Lituania 2
TW - Taiwan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AT - Austria 1
FR - Francia 1
IL - Israele 1
NZ - Nuova Zelanda 1
PE - Perù 1
PL - Polonia 1
UA - Ucraina 1
Totale 1.178
Città #
Chandler 167
Singapore 60
Santa Clara 47
Milan 40
Catanzaro 39
Princeton 37
Lawrence 36
Ashburn 30
London 30
Chicago 23
Wilmington 19
Des Moines 18
Seattle 16
Ottawa 11
Norwalk 10
Assago 6
Beijing 6
Genova 6
Guangzhou 6
Munich 6
Rome 6
Shanghai 6
Florence 5
Los Angeles 5
Siena 5
Toronto 5
Campi Salentina 4
Falls Church 4
Grottaglie 4
Helsinki 4
Naples 4
Redmond 4
Shenzhen 4
Boardman 3
Hanover 3
Lurate Caccivio 3
Napoli 3
Vasto 3
Arcene 2
Aversa 2
Bologna 2
Castrolibero 2
Catania 2
Jiaxing 2
Klaipėda 2
Leawood 2
Olomouc 2
Pune 2
Redwood City 2
Sermoneta 2
Tokyo 2
Villongo 2
West Jordan 2
Aachen 1
Albino 1
Amsterdam 1
Apo 1
Bhavnagar 1
Borås 1
Buffalo 1
Clearwater 1
Dongyang 1
Gaithersburg 1
Isola di Capo Rizzuto 1
La Canada Flintridge 1
Lamezia Terme 1
Laval 1
Lima 1
Madrid 1
Murcia 1
Nandyāl 1
Nanjing 1
Nantong 1
Nuremberg 1
Phoenix 1
Rende 1
Rotterdam 1
Roubaix 1
Saint Louis 1
Secaucus 1
Sezze 1
Suzhou 1
Taichung 1
Troina 1
Turin 1
Vancouver 1
Varese 1
Washington 1
Weifang 1
Wellington 1
Wuxi 1
Xiangtan 1
Xingtai 1
Totale 758
Nome #
Deregulation of SGK1 in Ulcerative Colitis: A Paradoxical Relationship Between Immune Cells and Colonic Epithelial Cells. 62
Preclinical model in HCC: the SGK1 kinase inhibitor SI113 blocks tumor progression in vitro and in vivo and synergizes with radiotherapy. 48
Alternative splicing regulation in tumour cells of gene encoding the tyrosine phosphatase PTPRJ 48
Germline Testing in a Cohort of Patients at High Risk of Hereditary Cancer Predisposition Syndromes: First Two-Year Results from South Italy 44
In Preclinical Model of Ovarian Cancer, the SGK1 Inhibitor SI113 Counteracts the Development of Paclitaxel Resistance and Restores Drug Sensitivity 42
The receptor protein tyrosine phosphatase PTPRJ negatively modulates the CD98hc oncoprotein in lung cancer cells. 41
A familial form of epidermolysis bullosa simplex associated with a pathogenic variant in krt5 40
The SGK1 Kinase Inhibitor SI113 Sensitizes Theranostic Effects of the 64CuCl2 in Human Glioblastoma Multiforme Cells 38
The human asparaginase enzyme (ASPG) inhibits growth in leukemic cells 38
SI113, a Specific Inhibitor of the Sgk1 Kinase Activity that Counteracts Cancer Cell Proliferation 36
SGK1, the serum- and glucocorticoid-regulated kinase, modulates the response to taxanes by regulating the GTPase RAN and its partners in colon carcinoma cells. 35
In silico identification and biological evaluation of novel selective serum/glucocorticoid-inducible kinase 1 inhibitors based on the pyrazolo-pyrimidine scaffold 35
Pyrrolo[2,3-d]pyrimidines active as Btk inhibitors 33
The Emerging Role of SGK1 (Serum- and Glucocorticoid-Regulated Kinase 1) in Major Depressive Disorder: Hypothesis and Mechanisms 33
SGK1 affects RAN/RANBP1/RANGAP1 via SP1 to play a critical role in pre-miRNA nuclear export: a new route of epigenomic regulation 32
Indole and 2,4-Thiazolidinedione conjugates as potential anticancer modulators 30
Determination of SGK1 mRNA in non-small cell lung cancer samples underlines high expression in squamous cell carcinomas. 29
Identification of a new mutation in the gene coding for hairless protein responsible for alopecia universalis: The importance of direct gene sequencing 29
Data on the effects of low iron diet on serum lipid profile in HCV transgenic mouse model 29
RANBP1 (RAN Binding Protein 1): The Missing Genetic Piece in Cancer Pathophysiology and Other Complex Diseases 28
Meccanismi genetici e molecolari della Sindrome X metabolica 28
60 kDa Lysophospholipase, a New Sgk1 MolecularnPartner Involved in the Regulation of ENaC 28
60kDa lysophospholipase, a new Sgk1 molecular partner involved in the regulation of ENaC 28
Sgk1 enhances RANBP1 transcript levels and decreases taxol sensitivity in RKO colon carcinoma cells. 28
Review about the multi-target profile of resveratrol and its implication in the SGK1 inhibition 28
Deregulation of SGK1 in Ulcerative Colitis: a paradoxical relationship between immune cells and colonic epithelial cells 27
IL-2 signals through Sgk1 and inhibits proliferation and apoptosis in kidney cancer cells 27
Pathophysiology of the insulin receptor signal transduction 26
Sgk1 activates MDM2-dependent p53 degradation and affects cell proliferation, survival, and differentiation 26
Sgk1 promotes cell proliferation, survival and epithelial dedifferentiation by activating HDM2 dependent p53 degradation 22
Th17-Gene Expression Profile in Patients with Chronic Venous Disease and Venous Ulcers: Genetic Modulations and Preliminary Clinical Evidence 19
SI113, a SGK1 inhibitor, potentiates the effects of radiotherapy, modulates the response to oxidative stress and induces cytotoxic autophagy in human glioblastoma multiforme cells. 19
SGK1 (serum/glucocorticoid regulated kinase 1) 18
Kinase Inhibitors in Genetic Diseases 17
Serum and glucocorticoid-regulated kinase Sgk1 inhibits insulin-dependent activation of phosphomannomutase 2 in transfected COS-7 cells 16
RANBP1 regulates the SGK1-dependent Th17 pathological differentiation: nuclear export hypothesis 13
RANBP1, a member of the nuclear-cytoplasmic trafficking-regulator complex, is the terminal-striking point of the SGK1-dependent Th17+ pathological differentiation 13
The small molecule SI113 synergizes with mitotic spindle poisons in arresting the growth of human glioblastoma multiforme 13
The kinase inhibitor SI113 induces autophagy and synergizes with quinacrine in hindering the growth of human glioblastoma multiforme cells. 13
SGK1, the New Player in the Game of Resistance: Chemo-Radio Molecular Target and Strategy for Inhibition 13
RFX-1, a putative alpha Adducin interacting protein in a human kidney library 12
The small molecule SI113 hinders epithelial-to-mesenchymal transition and subverts cytoskeletal organization in human cancer cells. 10
Germline Variant Spectrum in Southern Italian High-Risk Hereditary Breast Cancer Patients: Insights from Multi-Gene Panel Testing 9
Relative Resistance of SGK1 Knockout Mice Against Chemical Carcinogenesis 9
Metabolic drives affecting Th17/Treg gene expression changes and differentiation: impact on immune‐microenvironment regulation 7
The SGK1 Inhibitor SI113 Induces Autophagy, Apoptosis and Endoplasmic Reticulum Stress in Endometrial Cancer Cells 6
Spatial-transcriptomic profiling: a new lens for understanding myelofibrosis pathophysiology 5
The small molecule SI113 hinders epithelial-to-mesenchymal transition and subverts cytoskeletal organization in human cancer cells 4
Neglected Issues in T Lymphocyte Metabolism: Purine Metabolism and Control of Nuclear Envelope Regulatory Processes. New Insights into Triggering Potential Metabolic Fragilities 3
Totale 1.237
Categoria #
all - tutte 14.521
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.521


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202030 0 0 0 0 0 0 5 3 0 1 6 15
2020/202198 4 1 0 7 11 23 10 0 21 3 8 10
2021/2022138 2 0 2 39 3 12 5 16 22 17 20 0
2022/2023433 73 47 23 21 47 34 3 43 81 27 29 5
2023/2024234 38 29 11 18 15 58 2 24 5 7 14 13
2024/2025298 75 53 32 15 32 85 6 0 0 0 0 0
Totale 1.237